INTERNATIONAL CONGRESS OF CAD

Slides:



Advertisements
Similar presentations
Health Statistics and Informatics Global Burden of Disease 2004 Update: Selected figures and tables Health Statistics and Informatics Department.
Advertisements

GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.
Stroke Research in East Kent Prevention and Treatment Present and Future Dr Tom Webb Consultant Neurologist and Stroke Physician EKHUFT June 2014.
Epidemiology of Peripheral Vascular Disease Sohail Ahmed School of Population and Health Sciences.
Infant Mortality: Annual number of children under 1 year of age who die per 1,000 live births Under 5 Mortality/5 yr Child Survival Life Expectancy at.
CHILDHOOD INJURY PREVENTION CONFERENCE1. Child Pedestrian Injuries: A Global Problem Priti Gautam Thursday, June 20 2.
Dr Verity Blackwell West Hertfordshire Dermatology Team.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 4.
EPIDEMIOLOGY AND PREVENTION OF STROKE
Non-communicable diseases A global overview David Leon.
Epidemiology of Stroke Dexter L. Morris, PhD, MD Department of Emergency Medicine University of North Carolina School of Medicine Chapel Hill, NC.
Introduction to Public Health January 29,
Stroke - the size of the problem. What is a stroke? What is a transient ischaemic attack? What is the size of the problem?
Non-communicable diseases David Redfern
CARDIOVASCULAR DISEASE (CVD)
HPS: Heart Protection Study Purpose To determine whether simvastatin reduces mortality and vascular events in patients with and without coronary disease,
Population Mortality and Morbidity in Ireland n April 2001.
Joseph Perriëns MD, PhD Dept of HIV/AIDS World Health Organization
Cardiovascular Diseases and ECG tracings Cardiologist for the day!
INJURY EPIDEMIOLOGY & PREVENTION. Definitions Injury “Acute exposure to physical agents such as mechanical energy, heat, electricity, chemicals, and ionising.
Health transition and emerging cardiovascular disease in developing countries: situation and strategies for prevention Pascal Bovet,
Fibrinogen in South Asians Dr Kirti Kain MD MRCP Academic Unit of Molecular Vascular Medicine Leeds University Leeds United Kingdom.
Stroke John C. Stevenson Editor: Martin Birkhäuser.
Global and Regional estimates of the Burden Due to Ambient Air Pollution: results from GBD ST AFRICA/MIDDLE-EAST EXPERT MEETING AND WORKSHOP ON THE.
Cardiovascular Disease Middlesbrough Update for Middlesbrough Scrutiny Committee 4 th November 2014 Dr Tanja Braun.
Health Statistics and Informatics Non-communicable diseases A global overview.
Meeting the Challenge of Non-Communicable Diseases Lecture 14.
North West Surrey CCG Health Profile Health Profile Summary Population – current, projected & specific groups Wider determinants Health behaviours.
II Working Meeting on Adult Premature Mortality in European Union, October 2006, Warsaw, Poland Poland country report.
Epidemiological measureas. How do we determine disease frequency for a population?
Cardiovascular Risk: A global perspective
Key Health Indicators in Developing Countries and Australia
The role of unknown risk factors in coronary heart disease
Public Health in Latvia
Hypertension guidelines What’s all the controversy about 2015
Heart Disease in Indians
Pravastatin in Elderly Individuals at Risk of Vascular Disease
CANTOS: The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study
Cardiovascular risk factors: are they useful screening tests?
Hypertension Update: How Low Shall We Go?
Prevention Cardiovascular disease
DYSLIPIDEMIA AND ATHEROSCLEROSIS
Progress and Promise in RAAS Blockade
Nat. Rev. Cardiol. doi: /nrcardio
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
In the name of God.
Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.
Cardiovascular disease: Leading cause of death
MEASURING HEALTH STATUS
Lowering of SBP by 20 mm Hg Reduces Cardiovascular Risk by Half
WHO Statistics, 2000 Dr. Rüdiger Krech
Measurements of Risk & Association …
The Clock is ticking for the world’s leaders
Emerging Risk Factors Collaboration. JAMA 2009;302:412-23
High Risk of Heart Disease in South Asians
Flow chart of search strategy
DRAFT Wisbech PCN Data pack July 2019.
DRAFT Granta Data pack January 2019.
Ely South PCN Data pack August 2019.
Ely North PCN Data pack August 2019.
St. Neots PCN Data pack August 2019.
Wisbech PCN Data pack July 2019.
Cambridge City PCN Data pack July 2019.
South Peterborough PCN
Fenland PCN Data pack August 2019.
Octagon PCN Data pack August 2019.
North Alliance Data pack August 2019.
St. Ives PCN Data pack July 2019.
Woodlands PCN Data pack August 2019.
BMTRY 736 Foundation of Epidemiology Fall 2019
Presentation transcript:

INTERNATIONAL CONGRESS OF CAD REVIEW OF MAJOR NON MAJOR RISK FACTORS OF CORONARY ARTERY DISEASE IN “JAVAD AL AEMEH “ HEART HOSPOTAL OF MASHHAD. 5-7 OCT. 2011 Dr. M Mohammadi cardiologist

Agency for Health Care Policy and Research (AHCPR) 1995: Cardiovascular disease is the leading cause of morbidity and mortality in united states,accouting for 50% of all deaths.

Global Perspective Ischemic heart disease Ischemic heart disease leading causes of mortality 1990 leading causes of mortality 2020 Ischemic heart disease Cerebrovascular disease Lower respiratory disease ………………. Road – traffic accidents Throat and lung cancers Ischemic heart disease Unipolar major depression Road – traffic accidents Cerebrovascular disease COPD Lower respiratory disease ………………. War injuries HIV

2. Method 2.1. Study area and population From 21 November 2006 to 20 November 2007, patients with a new stroke in defined study areas (450129 residents) were identified.

No strokes were found in children aged less than 15 years. The incidence rates increased significantly with each decade of life and were similar in men and women

Ischaemic strokes are occurring approximately one decade earlier than in other countries

Discussion: Major finding 1- The incidence of stroke was approximately double that of the majority of ‘ideal’ studies conducted in the last decade 2-It was greater than in most western countries with the exception of the Ukraine 3-It was even higher than those of Novosibirsk, Russia; a region known for its high incidence of stroke 4-The crude incidence rate of stroke was relatively low which is related to our younger population. 5- Ischaemic strokes are occurring approximately one decade earlier than in other countries 6- The high incidence of total stroke is largely attributable to a high incidence of IS. 7-It also appears that the incidence of ICH is greater than in all other countries except Georgia Mihalka L, et al.A population study of stroke in West Ukraine: incidence, stroke services, and 30-day case fatality. Stroke. 2001. Tsiskaridze A, et al. Stroke incidence and 30-day case-fatality in a suburb of Tbilisi: results of the first prospective population-based study in Georgia. Stroke. 2004 Feigin VL, et al.Stroke epidemiology in Novosibirsk, Russia: a population-based study. Mayo Clin Proc. 1995.

Discussion: The reason for the high incidence of stroke in Mashhad, and the fact that stroke occurs at younger ages, is not clear: 1- It might be related to race-ethnic differences 2-Different types of vascular risk factors and their control, 3- The effect of socioeconomic status on stroke

Discussion:Risk factors When assessing risk factors: 1- The proportion of people with diabetes appears to be greater than in other stroke studies 2-There also seems to be a large proportion of stroke patients, particularly women, with a history of hypertension 3-Risk factors were not well controlled in our population Rothwell PM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004

Summary: In summary, the MSIS provided valid and comparative data on the incidence of stroke in Iran as an area in the Middle-East. The incidence of stroke, IS, and ICH were greater than incidence figures reported in most other regions of the world, and strokes occurred at younger ages.

RISK FACTORS FOR ATHEROTHROMBOTIC DISEASE SMOKING HYPERTENSION HYPERLIPDEMIA FAMILY HISTORY DIABETES MELITUS OBESITY

اثرسیگار بر(CAD) 676 بیمار کنگره سلامتی و سیگار بندر عباس-دی86

تعداد سیگاری ها در هر گروه سنی

جمعیت اماری مورد مطالعه 89-84 900بیمار

فراوانی سنی

نسبت مرد / زن در جمعیت مورد مطالعه

SMOKING/ 278cases /30.88%

HYPERTENSION 380cases 42.22%

HYPERLIPIDMIA 417cases 46.33%

DIABETES 226cases 25.11%

FAMILY HISTORY 250cases 27.77%

مقایسه کلی ریسک فاکتورها

تعداد مردان بدون ریسک فاکتور ماژور/کل مردان/کل جمعیت 40 تعداد مردان بدون ریسک فاکتور ماژور/کل مردان/کل جمعیت 40.99% بدون ریسک فاکتور ماژور

تعداد زنان بدون ریسک فاکتور ماژور/کل زنان /کل جمعیت 44 تعداد زنان بدون ریسک فاکتور ماژور/کل زنان /کل جمعیت 44.19% بدون ریسک فاکتور ماژور

ATHEROTHROMBOTIC RISK FACTORS: High sensitivity C –reactive pr. Homocysteine Lipoprotein(a) Fibrinogen D-dimer Abnormalities of intrinsic fibrinolysis